- $31.91bn
- $41.48bn
- $117.76bn
- 64
- 64
- 79
- 79
Annual income statement for Humana, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Premiums Earned | |||||
Net Investment Income | |||||
Total Revenue | 77,155 | 83,064 | 92,870 | 106,374 | 117,761 |
Losses, Benefits, and Adjustments | |||||
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 72,169 | 79,916 | 88,833 | 102,361 | 115,199 |
Operating Profit | 4,986 | 3,148 | 4,037 | 4,013 | 2,562 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,600 | 3,354 | 3,568 | 3,383 | 1,721 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,293 | 2,869 | 2,806 | 2,547 | 1,308 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3,367 | 2,933 | 2,806 | 2,489 | 1,207 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,367 | 2,933 | 2,806 | 2,489 | 1,207 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 25.3 | 23.5 | 22.8 | 23.3 | 13.2 |
Dividends per Share |